Reza Nejati

Reza Nejati

Fox Chase Cancer Center - Philadelphia / United States
Medical and Health Sciences / Pathology
AD Scientific Index ID: 4619867
-
person_outline Reza Nejati's MOST POPULAR ARTICLES
1-) The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasmsJD Khoury, E Solary, O Abla, Y Akkari, R Alaggio, JF Apperley, R Bejar, ...Leukemia 36 (7), 1703-1719, 20229882022
2-) NCCN guidelines insights: acute myeloid leukemia, version 2.2021: featured updates to the NCCN guidelinesDA Pollyea, D Bixby, A Perl, VR Bhatt, JK Altman, FR Appelbaum, ...Journal of the National Comprehensive Cancer Network 19 (1), 16-27, 20211792021
3-) Acute myeloid leukemia, version 3.2023, NCCN clinical practice guidelines in oncologyDA Pollyea, JK Altman, R Assi, D Bixby, AT Fathi, JM Foran, I Gojo, ...Journal of the National Comprehensive Cancer Network 21 (5), 503-513, 2023612023
4-) Prognostic significance of tumor infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemotherapyR Nejati, JB Goldstein, DM Halperin, H Wang, N Hejazi, A Rashid, ...Pancreas 46 (9), 1180, 2017592017
5-) Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomasJ Svoboda, SM Bair, DJ Landsburg, SD Nasta, SJ Nagle, SK Barta, ...Haematologica 106 (6), 1705, 2021572021